Immunotherapy for brain metastases and primary brain tumors-Reference-Cited by-同舟云学术

Immunotherapy for brain metastases and primary brain tumors

Published:2023-01 Issue: Volume:179 Page:113-120
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Di Giacomo Anna M.^ORCID,Mair Maximilian J.^ORCID,Ceccarelli Michele^ORCID,Anichini Andrea^ORCID,Ibrahim Ramy^ORCID,Weller Michael^ORCID,Lahn Michael^ORCID,Eggermont Alexander M.M.^ORCID,Fox Bernard^ORCID,Maio Michele^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference68 articles.

1. Association of immunotherapy with durable survival as defined by value frameworks for cancer care;Ben-Aharon;JAMA Oncol,2018

2. Long-term overall survival and predictors in anti-PD-1-naive melanoma patients with brain metastases treated with immune checkpoint inhibitors in the real-world setting: a multicohort study;Naik;J Immunother,2021

3. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial;Reardon;JAMA Oncol,2020

4. A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation;Maio;J Exp Clin Cancer Res,2021

5. Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy;Maio;Cancer Immunol Immunother,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases;Cancer Letters;2024-08

2. Sex-specific functional effect of IL-12 gene polymorphisms in brain tumours;Biotechnology & Biotechnological Equipment;2024-04

3. Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches;Journal of Translational Medicine;2024-03-01

4. Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial;European Journal of Cancer;2024-03

5. Aided Diagnosis Model Based on Deep Learning for Glioblastoma, Solitary Brain Metastases, and Primary Central Nervous System Lymphoma with Multi-Modal MRI;Biology;2024-02-05